Activation of nicotinic α7 acetylcholine receptor enhances long term potentation in wild type mice but not in APPswe/PS1ΔE9 mice
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 487 (3) , 325-329
Abstract
No abstract availableKeywords
Funding Information
- Danish Alzheimer's Disease Research Fund
- Danish Medical Research Council
- Novo Nordisk Foundation
- Lundbeck Foundation
- Bang Foundation
- Aarhus University Research Fund
This publication has 26 references indexed in Scilit:
- Synaptic contact number and size in stratum radiatum CA1 of APP/PS1ΔE9 transgenic miceNeurobiology of Aging, 2009
- α7 Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatmentNeuropharmacology, 2009
- Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTPNeuropharmacology, 2007
- Plaques, Tangles, and Memory Loss in Mouse Models of NeurodegenerationBehavior Genetics, 2006
- SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional ProfileNeuropsychopharmacology, 2006
- SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of SchizophreniaNeuropsychopharmacology, 2006
- Effects of nicotinic stimulation on cognitive performanceCurrent Opinion in Pharmacology, 2004
- Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP MouseExperimental Neurology, 2002
- Amyloid Peptide Aβ1‐42 Binds Selectively and with Picomolar Affinity to α7 Nicotinic Acetylcholine ReceptorsJournal of Neurochemistry, 2000
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995